Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3576
iShares Russell 2000 Value ETF
IWN
$14B
| $1.89M | ﹤0.01% |
10,426
+604
| +6% | +$108K |
2023 Q2
10 quarters
|
|
3577
CPI Aerostructures
CVU
$60.7M
| $1.88M | ﹤0.01% |
475,413
+14,620
| +3% | +$40K |
2023 Q1
11 quarters
|
|
3578
Aligos Therapeutics
ALGS
$13.1M
| $1.87M | ﹤0.01% |
200,395
+28,706
| +17% | +$271K |
2020 Q4
20 quarters
|
|
3579
ImmuCell
ICCC
$97.6M
| $1.86M | ﹤0.01% |
302,996
-5,706
| -2% | -$33.6K |
2014 Q3
45 quarters
|
|
3580
Phunware
PHUN
$35.8M
| $1.86M | ﹤0.01% |
1,007,179
| – | – |
2019 Q3
25 quarters
|
|
3581
ALX Oncology
ALXO
$144M
| $1.84M | ﹤0.01% |
1,630,940
+102,321
| +7% | +$155K |
2020 Q3
21 quarters
|
|
3582
Gain Therapeutics
GANX
$46.3M
| $1.84M | ﹤0.01% |
569,901
+35,549
| +7% | +$94.9K |
2023 Q1
11 quarters
|
|
3583
Aegon
AEG
$12.6B
| $1.83M | ﹤0.01% |
237,728
+78,526
| +49% | +$600K |
2016 Q4
36 quarters
|
|
3584
Manhattan Bridge Capital
LOAN
$36.4M
| $1.83M | ﹤0.01% |
392,999
+9,614
| +3% | +$47.6K |
2014 Q3
45 quarters
|
|
3585
Where Food Comes From
WFCF
$81.2M
| $1.83M | ﹤0.01% |
159,046
-1,865
| -1% | -$23K |
2021 Q2
18 quarters
|
|
3586
Tvardi Therapeutics
TVRD
$15.7M
| $1.83M | ﹤0.01% |
424,821
+5,654
| +1% | +$50.7K |
2014 Q1
47 quarters
|
|
3587
Trekor Metals
TGB
$2.5B
| $1.82M | ﹤0.01% |
322,003
+45,570
| +16% | +$214K |
2022 Q2
14 quarters
|
|
3588
Culp Inc
CULP
$44.1M
| $1.82M | ﹤0.01% |
510,553
+3,491
| +0.7% | +$13.8K |
2013 Q2
50 quarters
|
|
3589
OnKure Therapeutics
OKUR
$108M
| $1.82M | ﹤0.01% |
626,593
-51,633
| -8% | -$155K |
2021 Q2
18 quarters
|
|
3590
Pixelworks
PXLW
$33.5M
| $1.82M | ﹤0.01% |
285,472
+8,078
| +3% | +$61.9K |
2013 Q2
50 quarters
|
|
3591
SunocoCorp LLC
SUNC
$3.4B
| $1.81M | ﹤0.01% |
+36,729
| New | +$1.85M |
2025 Q4
0 quarters
|
|
3592
Bluerock Homes Trust
BHM
$30.8M
| $1.8M | ﹤0.01% |
168,239
-2,163
| -1% | -$21.3K |
2022 Q4
12 quarters
|
|
3593
Purple Innovation
PRPL
$5.93M
| $1.79M | ﹤0.01% |
103,738
| – | – |
2018 Q2
30 quarters
|
|
3594
Schwab US Dividend Equity ETF
SCHD
$123B
| $1.79M | ﹤0.01% |
65,099
+1,148
| +2% | +$31.2K |
2023 Q3
9 quarters
|
|
3595
Schwab Fundamental US Large Company Index ETF
FNDX
$28.8B
| $1.78M | ﹤0.01% |
65,507
+13,883
| +27% | +$371K |
2023 Q1
11 quarters
|
|
3596
Xtant Medical Holdings
XTNT
$38.1M
| $1.78M | ﹤0.01% |
2,272,591
-83,080
| -4% | -$60.4K |
2022 Q3
13 quarters
|
|
3597
Lipocine
LPCN
$18.9M
| $1.78M | ﹤0.01% |
221,867
| – | – |
2014 Q3
45 quarters
|
|
3598
Sono-Tek
SOTK
$66.5M
| $1.78M | ﹤0.01% |
430,795
+63,400
| +17% | +$264K |
2021 Q4
16 quarters
|
|
3599
Canton Strategic Holdings
CNTN
$136M
| $1.78M | ﹤0.01% |
586,647
+540,315
| +1,166% | +$1.54M |
2025 Q3
1 quarter
|
|
3600
MAIA Biotechnology
MAIA
$61.8M
| $1.77M | ﹤0.01% |
1,154,833
+51,688
| +5% | +$67.5K |
2023 Q2
10 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.